Our Efforts to Develop a COVID-19 Vaccine

Health
VaccineFeatureLead_790x500.jpg
VaccineFeatureLead_1000x450.jpg

Our Efforts to Develop a COVID-19 Vaccine

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES

Our People
Get to know DR. Annaliesa Anderson
Get to know DR. Annaliesa Anderson

GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES

Find out what life is like for her, and our other scientists, in the time of coronavirus.

LISTEN TO 'THE ANTIGEN' PODCAST

Podcasts
Listen to ;The Antigen' Podcast
Listen to ;The Antigen' Podcast

LISTEN TO 'THE ANTIGEN' PODCAST

Hear from leading experts about the past, present, and future of vaccines as well as people whose families have been impacted by vaccine-preventable diseases.

HOW ARE VACCINES DEVELOPED?

Our Science
How are vaccines Developed?
How are vaccines Developed?

HOW ARE VACCINES DEVELOPED?

Explore what it takes to develop a novel vaccine.

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

COVID-19 AND CANCER

Your Health
COVID-19 and Cancer
COVID-19 and Cancer

COVID-19 AND CANCER

We answer questions about the impact of Coronavirus on people with cancer, safeguards they can take to stay healthy & more.

WHAT YOU NEED TO KNOW ABOUT COVID-19

Your Health
What you need to know about COVID-19
What you need to know about COVID-19

WHAT YOU NEED TO KNOW ABOUT COVID-19

Practical advice to protect you and your family from coronavirus.

Latest News

Pfizer Inc. (NYSE: PFE) today announced that it and Wyeth recommend rejection of the unsolicited tender offer made by Huguenot Bond Liquidity, LLC (“Offeror”) on May 11, 2020 (as amended and restated on May 21, 2020) to purchase up to $162.5 million principal amount of Pfizer’s outstanding 7.200% notes due 2039 (the “Pfizer Notes”) and up to $130.0 million principal amount of Wyeth’s 5.950% notes due 2037 (the “Wyeth Notes” and together with the Pfizer Notes, the “Notes”). Wyeth is a wholly-…